Apex Healthcare Advisers Recommend Shareholders Accept Privatization Offer

MT Newswires Live12-08

Apex Healthcare (KLSE:AHEALTH) said its advisers deem the takeover offer to be "fair and reasonable" and advised the shareholders to accept it, according to a Monday circular issued on Bursa Securities.

A consortium led by private equity firm Quadria Capital and the company's CEO, Kee Kirk Chin, offered to acquire the remaining shares of the pharmaceutical company.

The advisers said the offer price of 2.64 ringgit per share represents a premium of about 16.81% to 25.12% to the estimated fair value per company share and historical market prices.

The offer is also reasonable considering that its shares were illiquid, the filing said.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2589338823?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-08 16:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2589338823","market":"hk","top_or_hot":-1,"title":"Apex Healthcare Advisers Recommend Shareholders Accept Privatization Offer","media":"MT Newswires Live","content":"<html><body><p> Apex Healthcare (KLSE:AHEALTH) said its advisers deem the takeover offer to be \"fair and reasonable\" and advised the shareholders to accept it, according to a Monday circular issued on Bursa Securities.</p><p>A consortium led by private equity firm Quadria Capital and the company's CEO, Kee Kirk Chin, offered to acquire the remaining shares of the pharmaceutical company.</p><p>The advisers said the offer price of 2.64 ringgit per share represents a premium of about 16.81% to 25.12% to the estimated fair value per company share and historical market prices.</p><p>The offer is also reasonable considering that its shares were illiquid, the filing said.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apex Healthcare Advisers Recommend Shareholders Accept Privatization Offer</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApex Healthcare Advisers Recommend Shareholders Accept Privatization Offer\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-12-08 16:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Apex Healthcare (KLSE:AHEALTH) said its advisers deem the takeover offer to be \"fair and reasonable\" and advised the shareholders to accept it, according to a Monday circular issued on Bursa Securities.</p><p>A consortium led by private equity firm Quadria Capital and the company's CEO, Kee Kirk Chin, offered to acquire the remaining shares of the pharmaceutical company.</p><p>The advisers said the offer price of 2.64 ringgit per share represents a premium of about 16.81% to 25.12% to the estimated fair value per company share and historical market prices.</p><p>The offer is also reasonable considering that its shares were illiquid, the filing said.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"XLV","symbol_name":"健康照护类股ETF-SPDR","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2589338823","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2589338823","pubTimestamp":1765180996,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Apex Healthcare  said its advisers deem the takeover offer to be \"fair and reasonable\" and advised the shareholders to accept it, according to a Monday circular issued on Bursa Securities.A consortium led by private equity firm Quadria Capital and the company's CEO, Kee Kirk Chin, offered to acquire the remaining shares of the pharmaceutical company.The advisers said the offer price of 2.64 ringgit per share represents a premium of about 16.81% to 25.12% to the estimated fair value per company share and historical market prices.The offer is also reasonable considering that its shares were illiquid, the filing said.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"XLV":"健康照护类股ETF-SPDR","BK4137":"综合支持服务","LABU":"三倍做多标普生物-Direxion","XBI":"SPDR S&P Biotech ETF","BK4588":"碎股","BK4585":"ETF&股票定投概念","HCSG":"Healthcare Svcs Group Inc","LU0128526141.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" ACC","LU0029874061.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" YDIS INC","BK4581":"高盛持仓"},"translate_title":"Apex Healthcare顾问建议股东接受私有化要约","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HCSG":1.5,"LABU":0.6,"XBI":0.6,"XLV":1.5},"content_text":"Apex Healthcare (KLSE:AHEALTH) said its advisers deem the takeover offer to be \"fair and reasonable\" and advised the shareholders to accept it, according to a Monday circular issued on Bursa Securities.A consortium led by private equity firm Quadria Capital and the company's CEO, Kee Kirk Chin, offered to acquire the remaining shares of the pharmaceutical company.The advisers said the offer price of 2.64 ringgit per share represents a premium of about 16.81% to 25.12% to the estimated fair value per company share and historical market prices.The offer is also reasonable considering that its shares were illiquid, the filing said.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2589338823","isCrawlerRequest":true}